Premium
COPANLISIB IN COMBINATION WITH RITUXIMAB‐BENDAMUSTINE IN PATIENTS WITH RELAPSED‐REFRACTORY DLBCL: A MULTICENTRIC PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI
Author(s) -
Novo M.,
Castellino A.,
Chiappella A.,
Ciccone G.,
Balzarotti M.,
Di Rocco A.,
Spina M.,
Vitolo U.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.167_2880
Subject(s) - bendamustine , medicine , rituximab , refractory (planetary science) , oncology , phases of clinical research , clinical trial , lymphoma , materials science , composite material
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom